Author： Kushner Brian H. Modak Shakeel Kramer Kim LaQuaglia Michael P. Yataghene Karima Basu Ellen M. Roberts Stephen S. Cheung Nai-Kong V.
Publisher： Blackwell Publishing
E-ISSN： 1097-0142|120|13|2050-2059
ISSN： 0008-543X
Source： Cancer, Vol.120, Iss.13, 2014-07, pp. : 2050-2059
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Chromosome 11 abnormality linked to poor outcome in neuroblastoma
Pharmacogenomics, Vol. 6, Iss. 4, 2005-06 ,pp. :
Access to resources
Recommend
Pharmacotherapy of neuroblastoma
By George Rani E Diller Lisa Bernstein Mark L
Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. :
Is the R and R* dichotomy real?
By Tuc S.
Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. :
`Striking variability' in prescribing for cirrhosis in Spain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 389, 2002-01 ,pp. :
Emerging drugs for neuroblastoma
Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. :